Rate My Professor Regis Lamberts

Throughout his research career, Lamberts has examined how the heart sustains its pump function under stress conditions. In the last decade, his investigations have concentrated on alterations in autonomic regulation and cardiac function associated with obesity and diabetes. More recently, this has expanded to the functional interplay between epicardial adipose tissue and the heart, particularly in the context of cardiac arrhythmias and obesity. Leveraging HeartOtago resources, he acquires functional biomedical data at cellular and organ levels, human myocardial tissue, and clinical information to foster translational insights essential for developing targeted therapies for individuals with metabolic diseases and arrhythmias. Key publications encompass 'Cross-talk between cardiac muscle and coronary vasculature' (Physiological Reviews, 2006), 'Reactive Oxygen Species–Induced Stimulation of 5′ AMP-Activated Protein Kinase Mediates Sevoflurane-Induced Cardioprotection' (Circulation, 2009), 'Type-2 diabetes increases autophagy in the human heart through promotion of Beclin-1 mediated pathway' (International Journal of Cardiology, 2016), and 'Cardiac effects of myoregulin in ischemia-reperfusion' (Peptides, 2024). With 122 publications accumulating over 2,000 citations, his scholarship exerts considerable influence in cardiovascular research. Lamberts has obtained significant funding, including a $194,385 Heart Foundation grant in 2018 for investigating CaMKII inhibition as a target for atherosclerosis.